Federated Hermes Inc. Sells 133,289 Shares of Edap Tms S.A. (NASDAQ:EDAP)

Federated Hermes Inc. cut its stake in Edap Tms S.A. (NASDAQ:EDAP) by 13.1% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 880,871 shares of the medical equipment provider’s stock after selling 133,289 shares during the quarter. Federated Hermes Inc. owned 2.39% of Edap Tms worth $4,651,000 as of its most recent filing with the Securities & Exchange Commission.

Other large investors have also recently made changes to their positions in the company. Milestone Investment Advisors LLC bought a new stake in shares of Edap Tms in the third quarter worth approximately $39,000. Summit Trail Advisors LLC bought a new stake in shares of Edap Tms in the third quarter worth approximately $77,000. Finally, Rock Springs Capital Management LP grew its stake in shares of Edap Tms by 14.6% in the third quarter. Rock Springs Capital Management LP now owns 1,360,000 shares of the medical equipment provider’s stock worth $9,547,000 after acquiring an additional 173,700 shares during the period. 62.74% of the stock is currently owned by institutional investors.

Edap Tms Stock Performance

Shares of NASDAQ EDAP opened at $7.28 on Friday. The firm has a 50 day moving average of $7.22 and a 200 day moving average of $6.29. The company has a current ratio of 2.84, a quick ratio of 2.30 and a debt-to-equity ratio of 0.04. The firm has a market capitalization of $270.09 million, a price-to-earnings ratio of -11.56 and a beta of 0.74. Edap Tms S.A. has a 12-month low of $3.60 and a 12-month high of $12.23.

Edap Tms (NASDAQ:EDAP) last announced its earnings results on Wednesday, March 27th. The medical equipment provider reported ($0.15) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.02) by ($0.13). Edap Tms had a negative net margin of 35.03% and a negative return on equity of 34.33%. The business had revenue of $21.27 million for the quarter, compared to the consensus estimate of $21.30 million. On average, research analysts anticipate that Edap Tms S.A. will post -0.31 earnings per share for the current year.

Wall Street Analysts Forecast Growth

Several analysts recently issued reports on the stock. StockNews.com lowered shares of Edap Tms from a “hold” rating to a “sell” rating in a research report on Friday, April 19th. HC Wainwright boosted their target price on shares of Edap Tms from $16.00 to $19.00 and gave the company a “buy” rating in a research report on Monday, April 1st.

About Edap Tms

EDAP TMS SA, together with its subsidiaries, develops, produces, markets, distributes, and maintains a portfolio of minimally invasive medical devices for the treatment of urological diseases in Asia, France, the United States, and internationally. The company operates through High Intensity Focused Ultrasound (HIFU), Extracorporeal ShockWave Lithotripsy (ESWL), and Distribution Services (DIST) segments.